Pulmonary Pharmacology & Therapeutics

雜志介紹

Pulmonary Pharmacology & Therapeutics雜志介紹

《Pulmonary Pharmacology & Therapeutics》是一本以English為主的未開放獲取國際優秀期刊，中文名稱肺藥理學與治療學，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.3，最新CiteScore 指數為6.2。

本刊近期中國學者發表的論文主要有：

• Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway

  Author: Guangxia Yang, Lei Lyu, Xinhua Wang, Liang Bao, Beili Lyu, Zikai Lin

• GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation

  Author: Lei Jiang, Qing Jiang, Songlin Yang, Shicong Huang, Xiaoli Han, Jun Duan, Shangha Pan, Mingyan Zhao, Shuliang Guo

• Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-κBp65 pathway

  Author: Jinyan Ye, Minqiang Guan, Yao Lu, Dan Zhang, Chengye Li, Caicun Zhou

• Effect of mesenchymal stromal (stem) cell (MSC) transplantation in asthmatic animal models: A systematic review and meta-analysis

  Author: Li-Bo Zhang, Min He

英文介紹

Pulmonary Pharmacology & Therapeutics雜志英文介紹

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.

Research Areas Include:

? All major diseases of the lung

? Physiology

? Pathology

? Drug delivery

? Metabolism

? Pulmonary Toxicology.